ANIP
ANI Pharmaceuticals, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$79.55+0.44%
Price as of Jul 20, 2026
ANIP ownership
ANI Pharmaceuticals, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$6.7M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +4.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Option | 3,313 | $49.51 |
| Jul 6, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Sell | 3,313 | $86.00 |
| Jun 30, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Sell | 2,850 | $84.12 |
| Jun 15, 2026 | Cook Meredithofficer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $82.03 |
| Jun 10, 2026 | HAUGHEY THOMASdirector | Sell | 2,000 | $80.88 |
| Jun 10, 2026 | Leonard Matthew Jdirector | Grant | 4,357 | — |
| Jun 10, 2026 | TANNENBAUM RENEE Pdirector | Grant | 4,357 | — |
| Jun 10, 2026 | Thoma Jeannedirector | Grant | 4,357 | — |
| Jun 10, 2026 | HAUGHEY THOMASdirector | Grant | 4,357 | — |
| Jun 10, 2026 | Pera Antonio Rdirector | Grant | 4,357 | — |
| Jun 9, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Option | 3,312 | $49.51 |
| Jun 9, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Sell | 3,312 | $80.00 |
| May 13, 2026 | Walsh Patrick Ddirector | Sell | 3,973 | $80.75 |
| May 13, 2026 | Walsh Patrick Ddirector | Sell | 10,000 | $80.63 |
| May 13, 2026 | Rowland Thomas Andrewofficer: SVP, HEAD - ESTABLISHED BRANDS | Sell | 459 | $79.21 |
| May 13, 2026 | Gutwerg Oriofficer: SVP, GENERICS | Sell | 2,772 | $79.50 |
| May 13, 2026 | Lalwani Nikhildirector, officer: PRESIDENT & CEO | Sell | 55,000 | $77.57 |
| May 13, 2026 | Cook Meredithofficer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $78.16 |
| Apr 13, 2026 | Cook Meredithofficer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $77.95 |
| Mar 13, 2026 | Mutz Christopherofficer: HEAD OF RARE DISEASE | Sell | 3,162 | $71.64 |
| Mar 13, 2026 | Rowland Thomas Andrewofficer: SVP, HEAD - ESTABLISHED BRANDS | Sell | 4,772 | $74.91 |
| Mar 13, 2026 | Cook Meredithofficer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $72.62 |
| Mar 10, 2026 | Gutwerg Oriofficer: SVP, GENERICS | Tax | 3,314 | $74.04 |
| Mar 10, 2026 | Mutz Christopherofficer: HEAD OF RARE DISEASE | Sell | 3,602 | $74.18 |
| Mar 10, 2026 | Davis Kristaofficer: SVP, CHIEF HR OFFICER | Sell | 1,485 | $75.00 |
| Mar 10, 2026 | Davis Kristaofficer: SVP, CHIEF HR OFFICER | Sell | 5,087 | $74.13 |
| Mar 10, 2026 | CAREY STEPHEN P.officer: SVP & CFO | Tax | 5,150 | $74.04 |
| Mar 10, 2026 | Lalwani Nikhildirector, officer: PRESIDENT & CEO | Tax | 17,060 | $74.04 |
| Mar 10, 2026 | Mutz Christopherofficer: HEAD OF RARE DISEASE | Tax | 3,314 | $74.04 |
| Mar 10, 2026 | Mutz Christopherofficer: HEAD OF RARE DISEASE | Sell | 2,121 | $74.22 |
Source: ANIP SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ANIP positions over the last 6 months (SEC Form 13F).
Increased
236
New positions
88
Reduced
161
Sold out
76
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 2.7M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 2.7M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 1.3M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 823K | May 15, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Increased | 820K | May 14, 2026 |
| STATE STREET CORP | Increased | 772K | May 15, 2026 |
| STATE STREET CORP | Increased | 727K | Feb 13, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 708K | May 15, 2026 |
| GOLDENTREE ASSET MANAGEMENT LP | New Position | 668K | May 14, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 600K | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 592K | May 15, 2026 |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | Reduced | 590K | Feb 11, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 564K | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 540K | Feb 17, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 536K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.